High-dose Cyclophosphamide and Rituximab without Stem Cell Transplantation: a Feasibility Study for Low Grade B cell, Transformed and Mantle Cell Lymphomas

Relapse after autologous stem cell transplantation for low-grade B-cell lymphoma is common secondary to ineffective conditioning and/or tumor autograft contamination. We investigated high-dose cyclophosphamide and rituximab without stem cell rescue as first-line or salvage-therapy in lymphomas. Afte...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gladstone, Douglas E., Bolaños-Meade, Javier, Huff, Carol Ann, Zahurak, Marianna, Flinn, Ian, Borrello, Ivan, Luznik, Leo, Fuchs, Ephraim, Kasamon, Yvette, Matsui, William, Powell, Jonathan, Levitsky, Hyam, Brodsky, Robert A., Ambinder, Richard, Jones, Richard J., Swinnen, Lode J.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3390263/
https://ncbi.nlm.nih.gov/pubmed/21756035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.594191
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires